Luminome

Peptides,
reimagined.

We design molecules for the language of skin.

Luminome combines computational intelligence and peptide biology to create a new generation of skincare ingredients.

The premise

Skin communicates
in molecules.
We design new ones.

Skin is a signalling environment. Cells coordinate renewal, barrier maintenance and the organisation of the extracellular matrix through short protein fragments that bind their partners with real specificity. Peptides are that vocabulary.

Cosmetic science has borrowed a handful of them — the ones that happened to be found first, in tissue, decades ago. They work because evolution shaped them for something adjacent to what we want.

The rest of the vocabulary has never been written down. That is the part we are interested in.

The platform

A design loop, not a screening campaign.

  1. 01

    Understand

    Models trained on peptide sequence, structure and measured behaviour learn how a change of one residue propagates into folding, binding and stability.

  2. 02

    Generate

    Rather than screening what already exists, we propose sequences that satisfy several objectives at once — shape, charge, solubility, robustness.

  3. 03

    Validate

    Candidates are synthesised and measured. Every result, positive or negative, returns to the model as training signal.

Signature method

We don't search for
ingredients. We design them.

A peptide is a sentence written in twenty letters. Its meaning — how it folds, what it binds, how long it survives — is set by the order of those letters. Reading that relationship in reverse is what our models do.

  1. 01 Sequence Twenty residues. A string of symbols.
  2. 02 Properties Grouped by charge, polarity and hydrophobicity.
  3. 03 Structure Folded into the conformation those properties imply.
An amino-acid sequence resolving into a peptide helixThe twenty-residue sequence KLAETVRSLIDKAFNQGYLE regroups by physicochemical class and then folds into a helical ribbon as the page scrolls.KLAETVRSLIDKAFNQGYLE
  • Hydrophobic
  • Polar
  • Charged
  • Conformational
Structural render of design candidate LM-0417A helical peptide ribbon in teal, suspended over a translucent gel form and a field of energy contours.

Featured design record

LM-0417

A helical fourteen-residue candidate, designed against a matrix-organisation objective and optimised for stability in an aqueous cosmetic base.

Class
α-helical peptide
Length
14 residues
Sequence
K L A E T V R S L I D K A F
Design objective
Selective binding, retained fold, protease resistance
Intended cosmetic function
Topical ingredient supporting the look of skin firmness
Status
In evaluation

Illustrative of the design records our platform produces. The sequence shown is a representative example, not a disclosed Luminome candidate.

Design space

Almost none of it has been looked at.

A peptide of twenty residues has 2020 possible sequences — around 100 septillion. Classical discovery walks into that space by hand and samples a few hundred at a time, guided by what has already been found in tissue.

Generative models let us treat the space as something to be navigated rather than stumbled through: propose broadly, rank against every objective at once, and take only the few candidates worth making.

From one natural peptide to a selected set of designed candidatesA single starting peptide on the left fans out into a wide cloud of faint candidate sequences, from which three optimised peptide structures are selected on the right.

From sequence to skin

A designed molecule still has to survive contact with reality.

  1. In silico design

    Objectives set, candidates generated and ranked.

  2. Synthesis

    Solid-phase synthesis and purification of the selected set.

  3. Biochemical testing

    Binding, stability and solubility measured directly.

  4. Skin models

    Reconstructed human epidermis and ex vivo tissue.

  5. Formulation

    Compatibility, stability and sensory work in finished bases.

Evidence

One standard,
applied to everything.

Cosmetic science has a credibility problem, and it is largely self-inflicted. We would rather publish less and mean it.

Vehicle controls on every assay

A treatment arm means nothing without the matched base it was delivered in.

Reported n and dispersion

Sample size, replicates and spread are published with the central estimate, never after it.

Endpoints fixed in advance

The measurement is chosen before the data exists, so a result cannot be selected into significance.

Independent replication

A finding becomes a claim only once it has been reproduced outside the group that found it.

Methods published with results

Protocols, concentrations and models are disclosed so the work can be checked.

Study data will be published on this page as work completes, with methods attached. We have not put placeholder charts here in the meantime.

Capabilities

What the system optimises against.

Conformational stability

Designing sequences that hold their intended fold rather than drifting between states.

Proteolytic stability

Backbones and residue choices selected to resist the proteases a topical peptide meets.

Aqueous solubility

Charge and hydrophobic patterning tuned so a candidate stays in solution at formulation pH.

Target selectivity

Shaping the binding interface toward one partner and away from close structural relatives.

Synthetic accessibility

Constraining designs to sequences that can actually be made at scale and at cost.

Formulation compatibility

Screening against the surfactants, emulsifiers and preservatives real products contain.

Mission

A new language for skin.

The most interesting molecules for skin have probably not been discovered yet, because discovery was never the constraint — imagination was, and after that, the sheer size of the search. Both of those have changed.

Luminome exists to design the ingredients that come next, and to hold them to a standard worth trusting.

Let's design
something new.

We work with formulators, brands and research groups who want ingredients that did not exist before.

hello@luminome.bio